Diebold, Inc. (DBD) Tops Q2 EPS by 13c, Reaffirms FY11 Guidance
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $63.20 -0.46%
Financial Fact:
Miscellaneous, net: -26.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Miscellaneous, net: -26.8M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q2 EPS of $0.44, $0.13 better than the analyst estimate of $0.31. Revenue for the quarter came in at $662.4 million versus the consensus estimate of $655.93 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
